Clinical Trials Browser

Phase 1/2 × NETWORK × Diffuse Intrinsic Pontine Glioma × Clear all

NCT04870944 2026-05-05

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Phase 1/2 Recruiting

Diffuse Intrinsic Pontine Glioma, Lymphoma